SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

A sharp selloff with no confirmed company-specific news is driving discussion, with traders blaming options expiration, broader biotech weakness and alleged stop-loss or short-selling pressure. Many are buying the dip and waiting for the REGAL trials next event update and final analysis, while others are frustrated by SELLASs prolonged quiet period and uncertainty around the data.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Teslas Roadster demonstration featuring SpaceX-developed thrusters is driving attention, with enthusiasts praising the engineering and skeptics questioning its practicality, safety, and likely contribution to sales. Some traders also view the TeslaSpaceX showcase as a possible signal of a future merger, though that remains speculation.

SK hynix, Inc. engages in the design, manufacture, and sale of semiconductor products. Its products include dynamic random access memory, not-AND flash memory, and multi-chip package. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynix is caught in a sharp semiconductor and South Korean market selloff, with traders focused on whether Chinas CXMT can become a meaningful DRAM competitor, alongside broader worries about AI investment returns, financing costs and memory-cycle normalization. Bulls argue CXMTs threat is years away and see the decline as overdone, while bears expect continued pressure on memory stocks.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Concerns about CoreWeaves debt-funded AI infrastructure expansion, including rising borrowing costs and refinancing risk, are weighing on the shares; reported insider selling has added to bearish scrutiny. Traders remain divided between seeing credit stress as a threat to the business and viewing the selloff as overdone given AI demand and Nvidias reassurance, with the rebound not settling the financing debate.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Goldman Sachs upgrade to Buy, alongside a wave of analyst target increases, is driving attention as traders weigh the endorsement against a pullback after a run to a 52-week high. Bullish investors see validation of Zetas enterprise growth and AI-marketing story, while others point to profit-taking, options-expiration effects, and the risk of buying after a sharp rally.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

A sharp semiconductor and AI-stock selloff, fueled by hotter inflation and rate concerns alongside worries about AI spending, valuations and weakness in Korean chip markets, is driving attention; SOXLs 3x leverage amplifies the moves. Traders are split between treating the pullback and extended losing streak as a buying opportunity and expecting further downside amid weak momentum.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

A cluster of open-market purchases by Celsius executives and directors is fueling bullish interest, with some traders interpreting the buying as a sign of confidence and expecting a rebound or short covering. Others remain skeptical, pointing to weak performance and concerns about the core Celsius brands sales and management.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

The EMA upheld its negative opinion on Omeros narsoplimab application for TA-TMA after re-examination, driving the sharp decline. Traders are split between viewing the European setback as a serious disappointment and arguing that U.S. YARTEMLEA demand remains the key business driver, with some buying the dip.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally is centered on anticipation for full Phase 3 data on its personalized melanoma vaccine, following positive topline results; traders are also debating whether the steep pullback reflects routine profit-taking or an overextended valuation ahead of the readout. Bulls remain focused on the cancer-vaccine opportunity, while skeptics cite cash burn and insider selling as risks.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

Renewed takeover speculation is driving attention, with traders interpreting reports of a possible all-stock bid from an unnamed West Coast tech company as potentially involving Meta, given its Muse commerce partnership with PayPal. No offer is confirmed, and the community is divided between bullish buyout hopes and skepticism that the rumor-driven move could fade.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$PANW $FTNT $CRWD  Disgusting how much insider selling is happening ... in fact how is this amount of compensation even justified. &#39;Analyst&#39; targets don&#39;t mean sh*t

Karam

M.L Young

Monn1985

mike bass

StockTwits Web

Palo Alto Networks Inc

Fortinet Inc

Crowdstrike Holdings Inc

  Disgusting how much insider selling is happening ... in fact how is this amount of compensation even justified. 'Analyst' targets don't mean sh*t